JSL
GSK icon

JT Stratford LLC’s GSK GSK Stock Holding History

JT Stratford LLC’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-33,156
Closed -$1.68M – 105
2017
Q3 		$1.68M Sell
33,156
-3,267
-9% -$166K 1.09% 35
2017
Q2 		$1.96M Buy
36,423
+1,781
+5% +$94.9K 1.38% 26
2017
Q1 		$1.83M Buy
+34,642
New +$1.76M 1.36% 27

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JT Stratford LLC's GSK Position: Q4 2017 in Review

JT Stratford LLC sold out of GSK (GSK) in Q4 2017, closing a stake of 33,156 shares — an estimated $1.68M sold.

JT Stratford LLC first reported a position in GSK in Q1 2017 and held it in 3 quarters. The position peaked at $1.96M in Q2 2017. 763 funds tracked by Wall St. Rank hold GSK as of Q4 2017.

  • JT Stratford LLC reported no remaining GSK position as of Q4 2017 after selling out during the quarter.
  • JT Stratford LLC sold 33,156 GSK shares in Q4 2017, an estimated $1.68M.
  • JT Stratford LLC first reported a position in GSK in Q1 2017 and held it in 3 quarters.
  • JT Stratford LLC's GSK position peaked at $1.96M in Q2 2017.
  • 763 funds tracked by Wall St. Rank held GSK as of Q4 2017.

Based on JT Stratford LLC's 13F filing for Q4 2017, filed 15 Feb 2018.